Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Golovics, P A
55  Ergebnisse:
Personensuche X
?
1

P661 Ustekinumab in Crohn's disease: A three-year multicent..:

Barkai, L J ; Gonczi, L ; Farkas, K...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1259-i1259 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P829 The Burden of Colorectal Cancer in Patients with Ulcer..:

Wetwittayakhlang, P ; Golovics, P ; Gonczi, L...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i961-i962 , 2023
Link: https://doi.org/10.1093/..
 
?
3

DOP56 Long-term disease progression and resective surgery r..:

Gonczi, L ; Lakatos, L ; Golovics, P A...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i127-i128 , 2023
Link: https://doi.org/10.1093/..
 
?
4

DOP63 Time Trends of Environmental and Socio-economical Fac..:

Wetwittayakhlang, P ; Gonczi, L ; Lakatos, L...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i137-i137 , 2023
Link: https://doi.org/10.1093/..
 
?
5

DOP26 Burden of perianal disease and perianal surgery in Cr..:

Gonczi, L ; Lakatos, L ; Golovics, P A...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i90-i91 , 2023
Link: https://doi.org/10.1093/..
 
?
6

P837 Incidence, evolution of disease phenotype, time to bio..:

Gonczi, L ; Lakatos, L ; Golovics, P A...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i966-i967 , 2023
Link: https://doi.org/10.1093/..
 
?
7

OP09 Long-term Colectomy rates of Ulcerative Colitis over 4..:

Lakatos PhD, P L ; Gonczi, L ; Lakatos, L...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i14-i16 , 2023
Link: https://doi.org/10.1093/..
 
?
8

P640 Incidence, prevalence, disease phenotype and maximal t..:

Lakatos, L ; Gonczi, L ; Golovics, P...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i557-i558 , 2022
Link: https://doi.org/10.1093/..
 
?
9

P658 Evolution of disease phenotype, time to biological the..:

Gonczi, L ; Lakatos, L ; Golovics, P...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i569-i570 , 2022
Link: https://doi.org/10.1093/..
 
?
10

A180 CLINICAL OUTCOMES OF COVID-19 AND IMPACT ON DISEASE CO..:

Wetwittayakhlang, P ; Albader, F ; Golovics, P...
Journal of the Canadian Association of Gastroenterology.  5 (2022)  Supplement_1 - p. 61-63 , 2022
Link: https://doi.org/10.1093/..
 
?
11

P451 Evaluating drug sustainability, efficacy and safety of..:

Golovics, P ; LeBlanc, J F ; Drügg Hahn, G...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i430-i431 , 2022
Link: https://doi.org/10.1093/..
 
?
12

A143 SAFETY OF BIOLOGICAL THERAPIES IN ELDERLY IBD: A SYSTE..:

Golovics, P ; Drügg Hahn, G ; Wetwittayakhlang, P...
Journal of the Canadian Association of Gastroenterology.  5 (2022)  Supplement_1 - p. 16-17 , 2022
Link: https://doi.org/10.1093/..
 
?
13

P635 Incidence, prevalence, disease phenotype and maximal t..:

Lakatos, L ; Gonczi, L ; Golovics, P...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i554-i555 , 2022
Link: https://doi.org/10.1093/..
 
?
14

P318 Safety of Biological Therapies in Elderly IBD: a Syste..:

Drügg Hahn, G ; Golovics, P ; Wetwittayakhlang, P...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i341-i342 , 2022
Link: https://doi.org/10.1093/..
 
?
15

DOP25 Clinical outcomes of COVID-19 and Impact on Disease C..:

Wetwittayakhlang, P ; Albader, F ; Golovics, P...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i077-i078 , 2022
Link: https://doi.org/10.1093/..
 
1-15